Standex International director Thomas E. Chorman sold 50 shares of Common Stock in an open-market transaction. The shares were sold at a price of $272.82 per share.
After this sale, Chorman directly holds 12,466 shares. The transaction was executed under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating it was pre-scheduled.
Filer submitted a Form 144 notice reporting proposed sales of Common Stock tied to restricted stock vesting and compensation. The excerpt lists multiple 50-share transactions by Thomas Chorman on 03/02/2026, 04/01/2026, and 05/01/2026 with per-share amounts shown. The securities record a grant/vesting date of 10/26/2024.
Standex International director Barbara Joanne Edwards reported an open-market sale of 558 shares of Common Stock on May 27, 2026 at $274.81 per share. After this transaction, she directly holds 5,669 shares, indicating a relatively small, routine-sized disposition.
Rangel Danielle reported acquisition or exercise transactions in this Form 4 filing.
Standex International reported that VP & Chief Accounting Officer Danielle Rangel received a grant of 603 Restricted Stock Units tied to common stock. The award was granted at no cost and will vest in three equal installments on May 15, 2027, May 15, 2028, and May 15, 2029.
Standex International Corporation announced that Ademir Sarcevic, currently Vice President, Chief Financial Officer & Treasurer, has been promoted to Executive Vice President – Corporate and Group President – Electronics. He will retain his Chief Financial Officer role until a successor is found to support a smooth transition.
In his expanded role, Sarcevic will lead growth initiatives across the Electronics segment and oversee selected corporate projects and initiatives. To recognize this promotion, Standex approved a special incentive award of $750,000 in restricted stock units, scheduled to be granted on July 1, 2026 under the company’s equity incentive plan.
One-third of these restricted stock units will vest on the second anniversary of the grant date and the remaining two-thirds on the third anniversary, contingent on Sarcevic’s continued service with the company. Standex highlights his contributions since joining as CFO in 2019, including strengthening the finance organization, improving margins, and enhancing capital allocation and investor relations.
Standex International Corporation reported sharply stronger results for the three and nine months ended March 31, 2026, helped by a business sale and solid organic growth. Net sales from continuing operations rose to $224.6 million for the quarter and $663.3 million for the nine-month period, up from $207.8 million and $568.1 million a year earlier.
Quarterly income from continuing operations climbed to $68.6 million versus $22.8 million, with diluted EPS from total operations increasing to $5.55 from $1.81. Results include a $56.8 million pre-tax gain (about $49.0 million after tax) on the March 2026 divestiture of the Federal Industries display merchandising business for $68.3 million in cash proceeds.
Standex realigned into four segments—Electronics, Aerospace & Defense, Scientific, and Engraving & Hydraulics—and continued integrating the Amran/Narayan Group and McStarlite acquisitions. Long-term debt decreased to $472.8 million, and operating cash flow from continuing operations improved to $49.4 million for the nine-month period.
Standex International reported strong fiscal third quarter 2026 results, with net sales of $224.6 million, up 8.1% year-on-year, and GAAP diluted EPS of $5.56 boosted by a gain on the Federal Industries divestiture.
Adjusted diluted EPS rose to $2.21, up 13.5%, and adjusted operating margin edged up to 19.7%. Electronics revenue grew 7.6% to $119.7 million, while Aerospace & Defense jumped 33.7% to $36.6 million, helped by the McStarlite acquisition and space-related projects.
The company completed the Federal Industries sale at about $70 million enterprise value, used to pay down roughly $62 million of debt, reducing net debt to EBITDA to 1.9x. Management now expects about $100 million of incremental fiscal 2026 sales and fast growth market revenue of roughly $270 million.
Standex International director Thomas E. Chorman reported a small open-market sale of company stock. On this Form 4, he sold 50 shares of Standex International common stock at an average price of $268.43 per share on May 1, 2026, and held 12,516 shares afterward. The filing notes that this sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, indicating the transaction was pre-planned rather than timed discretionarily.
SXI issuer notice: Thomas Chorman reported a proposed sale of 50 Common shares via Fidelity Brokerage Services LLC under a Form 144 notice dated 05/01/2026. The filing also lists multiple prior dispositions in the past three months, including 513 shares sold on 02/27/2026.